35 Days
Source:
الخليج
FDA Approves First Home Treatment for Alzheimer's Disease in the United States
The U.S. Food and Drug Administration (FDA) has approved a new treatment for Alzheimer's disease called lecanemab-irmb, which can now be administered at home through subcutaneous injections for early-stage patients, instead of intravenous injections at medical centers. This comes after positive results from two large studies showing that the IV treatment helped slow disease progression by targeting amyloid buildup in the brain, a hallmark of the condition. While the convenience of home treatment reduces the need for frequent visits to medical facilities, the agency warned about potential side effects such as headaches, swelling, brain hemorrhages, and other symptoms. It also recommends genetic testing before starting therapy to avoid complications related to certain genetic mutations.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)